1st Quarter - Report
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP for STRONGBRIDGE BIOPHARMA PLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Client
Income
$130,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2018 | $130,000 | Replaced |
| 1st Quarter - Amendment | Apr 20, 2018 | $130,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to Drug Pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN BENTIVOGLIO | — |
| AVIA DUNN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.